HI
STOK icon

Harbour Investments’s Stoke Therapeutics STOK Stock Holding History

Harbour Investments’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
3,352
+2,167
+183% +$71.1K ﹤0.01% 1881
2025
Q4 		$37.6K Buy
1,185
+898
+313% +$27K ﹤0.01% 2098
2025
Q3 		$6.75K Buy
287
+237
+474% +$4.06K ﹤0.01% 2863
2025
Q2 		$568 Hold
50
– – ﹤0.01% 3353
2025
Q1 		$333 Hold
50
– – ﹤0.01% 3383
2024
Q4 		$552 Hold
50
– – ﹤0.01% 3268
2024
Q3 		$615 Hold
50
– – ﹤0.01% 3172
2024
Q2 		$676 Buy
+50
New +$675 ﹤0.01% 3050

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Harbour Investments's STOK Position: Q1 2026 in Review

Harbour Investments increased its Stoke Therapeutics (STOK) stake by 183% in Q1 2026, buying an estimated $71.1K and bringing the position to 3,352 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Harbour Investments first reported a position in STOK in Q2 2024 and has held it in 8 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Harbour Investments held 3,352 shares of Stoke Therapeutics worth $109K as of Q1 2026.
  • Harbour Investments bought 2,167 Stoke Therapeutics shares in Q1 2026, an estimated $71.1K.
  • Stoke Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1881 holding.
  • Harbour Investments first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.